COVID-19 Associated Coagulopathy in an Indian Scenario: A Correlation with Disease Severity and Survival Status

被引:0
|
作者
Sujata Raychaudhuri
Mukta Pujani
Reetika Menia
Nikhil Verma
Mitasha Singh
Varsha Chauhan
Manjula Jain
R. K. Chandoke
Harnam Kaur
Snehil Agrawal
Aparna Singh
机构
[1] ESIC Medical College,Department of Pathology
[2] ESIC Medical College,Department of Medicine
[3] ESIC Medical College,Department of Community Medicine
[4] ESIC Medical College,Department of Biochemistry
关键词
Covid-19; Coagulopathy; D dimer; FDP; Indian population;
D O I
暂无
中图分类号
学科分类号
摘要
Covid-19 pandemic reveals that the virus causes Covid-19 associated coagulopathy and it is well known that thrombotic risk is associated with ethnicity. To describe the Covid-19 associated coagulopathy in Indian population and to correlate it with the disease severity and survivor status. A cross sectional descriptive study of 391 confirmed Covid-19 cases was carried out over a period of 1.5 months. Patients were categorised as mild to moderate, severe and very severe and also labelled as survivors and non survivors. Prothrombin time (PT), International normalised ratio (INR), activated partial thromboplastin time, D dimer, Fibrin degradation products (FDP), fibrinogen and thrombin time and platelet counts were investigated among the subgroups. Mean age was higher in patients with severe disease (57.62 ± 13.08) and among the non survivors (56.54 ± 12.78). Statistically significant differences in D dimer, FDP, PT, INR and age were seen among the 3 subgroups and survivors. Strong significant positive correlation was noted between D dimer and FDP (r = 0.838, p < .001), PT and INR (r = 0.986, p < 0.001). D dimer was the best single coagulation parameter as per the area under curve (AUC: 0.762, p < 0.001) and D dimer + FDP was the best combination parameter (AUC: 0.764, p = 0) to differentiate mild moderate from severe disease. Raised levels of D dimer, FDP, PT, PT INR and higher age correlated positively with disease severity and mortality in Indian Population.
引用
收藏
页码:341 / 351
页数:10
相关论文
共 50 条
  • [21] Coagulopathy and COVID-19
    Yazici, Onur
    Bozkus, Fulsen
    Demirci, Nilgun
    Gulhan, Pinar Yildiz
    Coskun, Funda
    [J]. EURASIAN JOURNAL OF PULMONOLOGY, 2020, 22 (04) : 67 - 69
  • [22] COVID-19 and coagulopathy
    Sarkar, Malay
    Madabhavi, Irappa, V
    Pham Nguyen Quy
    Govindagoudar, Manjunath B.
    [J]. CLINICAL RESPIRATORY JOURNAL, 2021, 15 (12): : 1259 - 1274
  • [23] Coagulopathy in COVID-19
    Iba, Toshiaki
    Levy, Jerrold H.
    Levi, Marcel
    Thachil, Jecko
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (09) : 2103 - 2109
  • [24] COVID-19 Coagulopathy
    Rettew, Andrew
    Garrahy, Ian
    Rahimian, Shoja
    Brown, Rebecca
    Sangha, Navdeep
    [J]. LIFE-BASEL, 2024, 14 (08):
  • [25] Coagulopathy in COVID-19
    Lio, Ka U.
    Rali, Parth
    [J]. LUNG INDIA, 2021, 38 (07) : S53 - S57
  • [26] COVID-19 coagulopathy
    Katyal, Anup
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2020, 87 (12) : 712 - 712
  • [27] COVID-19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance
    Cannegieter, Suzanne C.
    Klok, Frederikus A.
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (04) : 439 - 445
  • [28] Teledermatology in the Wake of COVID-19 Scenario: An Indian Perspective
    Ashique, Karalikkattil T.
    Kaliyadan, Feroze
    [J]. INDIAN DERMATOLOGY ONLINE JOURNAL, 2020, 11 (03) : 301 - 306
  • [29] Impact of COVID-19 on Clinical Biochemistry: Indian Scenario
    Prasenjit Mitra
    Sanjeev Misra
    Praveen Sharma
    [J]. Indian Journal of Clinical Biochemistry, 2021, 36 : 385 - 386
  • [30] COVID-19 and Cleft and Craniofacial Surgery in Indian Scenario
    Manikandhan Ramanathan
    Sailesh Kumar Ravichandran
    Anantanarayanan Parameswaran
    [J]. Journal of Maxillofacial and Oral Surgery, 2022, 21 : 460 - 465